Lacosamide

Lacosamide ATC Code N03AX18 : Nervous system - Antiepileptics - Antiepileptic drugs - Other antiepileptics - Lacosamide
Lacosamide
Lacosamide
LatinLacosamidum
Routesoral and intravenous
Pregnancy categoryC
FDA Approval Date2008-10-28
EMA Approval Date2008-08-29
Molecular FormulaC13H18N2O3
Molecular Weight250.29362 g/mol
CAS Number175481-36-4
Lacosamide 3D

Lacosamide list of brand/trade names

  • United States: Vimpat
  • United Kingdom: Vimpat
  • Germany: Vimpat
  • France: Vimpat
  • Spain: Vimpat
  • Italy: Vimpat
  • Canada: Vimpat
  • Australia: Vimpat
  • Netherlands: Vimpat
  • Belgium: Vimpat
  • Denmark: Vimpat
  • Finland: Vimpat
  • Greece: Vimpat
  • India: Lacasa
  • Ireland: Vimpat
  • Norway: Vimpat
  • Portugal: Vimpat
  • Sweden: Vimpat
  • Switzerland: Vimpat
  • Turkey: Benvida, Matisse and Vimpat


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib